Skip to content

NJ ME/CFSA

This website is secure – as evidenced by “https” preceeding the web address. 3/05/2019

  • Home
  • About ME/CFS
  • Links
  • Contact Us
  • Support Groups
  • Scholarships
  • Anesthesia
  • Disability
  • Resources
  • Primers
  • Toggle search form

Ampligen in Long COVID

Posted on September 18, 2021 By Pat

https://aimimmuno.com/press-release/aim-immunotech-announces-filing-of-provisional-patent-application-for-use-of-ampligen-as-both-an-intranasal-and-an-iv-therapy-for-post-covid-19-cognitive-dysfunction-pccd/

Breaking News, Uncategorized

Post navigation

Previous Post: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management
Next Post: 2022 HS Scholarship

CRISIS INFO
SEEK HELP
CALL 988

DONATE or PAY DUES
Click Here
Subscribe to NJ ME/CFSA by email!
Please enable JavaScript in your browser to complete this form.
Name *
Loading

About NJMECFSA

We are patients and families with ME/CFS. We are here to support, inform and help you to deal with this serious illness.

Secure Website

This website is secure – as evidenced by “https” preceeding the web address. -3/05/2019

ICD-10!!!

Share this code information with your health care providers in order to have ME/CFS recognized and acknowledged properly

Copyright © 2025 NJ ME/CFSA.

Powered by PressBook Premium theme